Alexion Pharma Lays Off 7 Percent of Workers

Mar 13, 2017

Reuters

Alexion Pharmaceuticals, a biopharmaceutical company specializing in rare diseases, has announced a restructuring that will impact about 7 percent of its workforce, according to a Reuters article. As of Dec. 31, the company had 3,121 employees.

Alexion's chief executive and chief financial officer resigned in December after the board had reportedly lost confidence in them. Alexion said that CEO David Hallal resigned for personal reasons, while CFO Vikas Sinha left to pursue other opportunities.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments